BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 15908327)

  • 1. Determination of serum carbohydrate-deficient transferrin in the diagnosis of alcoholic liver disease.
    Liu YS; Xu GY; Cheng DQ; Li YM
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):265-8. PubMed ID: 15908327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.
    Imbert-Bismut F; Naveau S; Morra R; Munteanu M; Ratziu V; Abella A; Messous D; Thabut D; Benhamou Y; Poynard T
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):18-27. PubMed ID: 19011575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of determining carbohydrate-deficient transferrin isoforms in the diagnosis of alcoholic liver disease.
    Stadheim LM; O'Brien JF; Lindor KD; Gores GJ; McGill DB
    Mayo Clin Proc; 2003 Jun; 78(6):703-7. PubMed ID: 12934779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carbohydrate-deficient transferrin. A new, highly specific marker for chronic alcohol consumption].
    Seitz G; Stickel F; Fiehn W; Werle E; Simanowski UA; Seitz HK
    Dtsch Med Wochenschr; 1995 Mar; 120(12):391-5. PubMed ID: 7705200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction.
    Stauber RE; Stepan V; Trauner M; Wilders-Truschnig M; Leb G; Krejs GJ
    Alcohol Alcohol; 1995 Mar; 30(2):171-6. PubMed ID: 7662035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.
    Hietala J; Koivisto H; Anttila P; Niemelä O
    Alcohol Alcohol; 2006; 41(5):528-33. PubMed ID: 16799164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asialotransferrin discriminating excessive, subacute and chronic active alcohol consumption. Clinical usefulness in hepatic disease].
    Peneda JA; Fonseca A; Neves M; Ribeiro P; Alves M; Redondo I; Calinas F; Martins MC
    Acta Med Port; 1996; 9(2-3):103-11. PubMed ID: 8967303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
    Conigrave KM; Degenhardt LJ; Whitfield JB; Saunders JB; Helander A; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Mar; 26(3):332-9. PubMed ID: 11923585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume in alcohol-dependent patients.
    Mundle G; Munkes J; Ackermann K; Mann K
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1400-5. PubMed ID: 11003206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of carbohydrate-deficient transferrin by isoelectric focusing/western blotting and by micro anion-exchange chromatography/radioimmunoassay: comparison of diagnostic accuracy.
    Xin Y; Rosman AS; Lasker JM; Lieber CS
    Alcohol Alcohol; 1992 Jul; 27(4):425-33. PubMed ID: 1418115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between acetaldehyde-modified haemoglobin, carbohydrate-deficient transferrin (CDT) and haematological abnormalities in chronic alcoholism.
    Wickramasinghe SN; Corridan B; Hasan R; Marjot DH
    Alcohol Alcohol; 1994 Jul; 29(4):415-23. PubMed ID: 7986279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies on sugar chains of carbohydrate-deficient transferrin from patients with alcoholic liver disease using lectin affinity electrophoresis.
    Inoue T; Yamauchi M; Ohkawa K
    Electrophoresis; 1999 Mar; 20(3):452-7. PubMed ID: 10217151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate-deficient transferrin as a marker of alcohol abuse: relationship to alcohol consumption, severity of liver disease, and fibrogenesis.
    Niemelä O; Sorvajärvi K; Blake JE; Israel Y
    Alcohol Clin Exp Res; 1995 Oct; 19(5):1203-8. PubMed ID: 8561291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of body iron stores in the indicators of alcohol abuse and alcoholic liver injury].
    Cylwik B; Daniluk M; Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2010 Jun; 28(168):450-3. PubMed ID: 20642102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
    Halm U; Tannapfel A; Mössner J; Berr F
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy.
    Stejskal D; Růzicka V; Fanfrdlová G; Kolár V; Bartek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):93-9. PubMed ID: 16170395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of diagnostic validity of carbohydrate-deficient transferrin and other laboratory markers in chronic ethanol abuse].
    Moravcová E; Bednarík J; Dastych M; Novotná H; Pokora J
    Cas Lek Cesk; 2004; 143(1):39-43. PubMed ID: 15061118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study.
    Anton RF; Lieber C; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Aug; 26(8):1215-22. PubMed ID: 12198396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bayesian Alcoholism Test had better diagnostic properties for confirming diagnosis of hazardous and harmful alcohol use.
    Korzec A; de Bruijn C; van Lambalgen M
    J Clin Epidemiol; 2005 Oct; 58(10):1024-32. PubMed ID: 16168348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.